DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 158 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,591,705 | +40.3% | 901,476 | +37.7% | 0.05% | +2.1% |
Q3 2022 | $6,837,000 | -40.3% | 654,857 | -28.0% | 0.05% | -43.5% |
Q2 2022 | $11,445,000 | +14206.2% | 909,019 | +11076.9% | 0.08% | +8400.0% |
Q1 2021 | $80,000 | -4.8% | 8,133 | -56.7% | 0.00% | -50.0% |
Q4 2020 | $84,000 | +200.0% | 18,775 | +190.2% | 0.00% | +100.0% |
Q3 2020 | $28,000 | -78.8% | 6,469 | -39.1% | 0.00% | -80.0% |
Q3 2018 | $132,000 | +140.0% | 10,624 | +263.2% | 0.01% | +25.0% |
Q4 2017 | $55,000 | – | 2,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |